tradingkey.logo
tradingkey.logo
Suchen

Xtant Medical Holdings Inc

XTNT
Zur Watchlist hinzufügen
0.420USD
-0.001-0.24%
Handelsschluss 07/01, 16:00ETKurse um 15 Minuten verzögert
58.91MMarktkapitalisierung
31.91KGV TTM

mehr Informationen über Xtant Medical Holdings Inc Unternehmen

Xtant Medical Holdings, Inc. is a global medical technology company. The Company is focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity, and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. Its biomaterial products include OsteoSponge, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, OsteoVive, OsteoFactor, line of 3Demin products, as well as other allografts. It offers a comprehensive line of products that are used to treat a variety of spinal and sacroiliac conditions, including trauma, degeneration, deformity and tumor. Its key spinal implant product lines include Cervical products, Thoracolumbar products, Sacroiliac Joint products, Interbody products and Interlaminar Stabilization products.

Xtant Medical Holdings Inc Informationen

BörsenkürzelXTNT
Name des UnternehmensXtant Medical Holdings Inc
IPO-datumJun 30, 2010
CEOBrowne (Sean E)
Anzahl der mitarbeiter217
WertpapierartOrdinary Share
GeschäftsjahresendeJun 30
Addresse664 Cruiser Lane
StadtBELGRADE
BörseNASDAQ OMX – NASDAQ Basic Amex
LandUnited States of America
Postleitzahl59714
Telefon14063880480
Websitehttps://xtantmedical.com/
BörsenkürzelXTNT
IPO-datumJun 30, 2010
CEOBrowne (Sean E)

Führungskräfte von Xtant Medical Holdings Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Stavros G. Vizirgianakis
Mr. Stavros G. Vizirgianakis
Independent Chairman of the Board
Independent Chairman of the Board
6.96M
--
Mr. John K. Bakewell
Mr. John K. Bakewell
Independent Director
Independent Director
755.89K
--
Mr. Scott C. Neils
Mr. Scott C. Neils
Chief Financial Officer
Chief Financial Officer
370.27K
+0.00%
Mr. Abhinav (Abi) Jain
Mr. Abhinav (Abi) Jain
Director
Director
158.23K
--
Mr. Robert E. Mcnamara
Mr. Robert E. Mcnamara
Independent Director
Independent Director
--
--
Mr. Sean E. Browne
Mr. Sean E. Browne
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Mark A. Schallenberger
Mr. Mark A. Schallenberger
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Jonn R. Beeson
Mr. Jonn R. Beeson
Independent Director
Independent Director
--
--
Ms. Lori D. Mitchell-Keller
Ms. Lori D. Mitchell-Keller
Independent Director
Independent Director
--
--
Mr. Tyler P. Lipschultz
Mr. Tyler P. Lipschultz
Director
Director
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Stavros G. Vizirgianakis
Mr. Stavros G. Vizirgianakis
Independent Chairman of the Board
Independent Chairman of the Board
6.96M
--
Mr. John K. Bakewell
Mr. John K. Bakewell
Independent Director
Independent Director
755.89K
--
Mr. Scott C. Neils
Mr. Scott C. Neils
Chief Financial Officer
Chief Financial Officer
370.27K
+0.00%
Mr. Abhinav (Abi) Jain
Mr. Abhinav (Abi) Jain
Director
Director
158.23K
--
Mr. Robert E. Mcnamara
Mr. Robert E. Mcnamara
Independent Director
Independent Director
--
--
Mr. Sean E. Browne
Mr. Sean E. Browne
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von Xtant Medical Holdings Inc?

Die fünf größten Anteilseigner von Xtant Medical Holdings Inc sind: Mr. Stavros G. Vizirgianakis

Was ist die größte Einnahmequelle von Xtant Medical Holdings Inc?

Am 2026Q4 erzielte das Geschäft mit Orthobiologics für Xtant Medical Holdings Inc den höchsten Umsatz in Höhe von 72.89M, was 54.43% des Gesamtumsatzes entspricht.